SUPPLEMENT
Q2 2024 — Income statement trends
Q2 2024PDF · 2 pages143 KB
CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q222 Q322 Q422 Q123 Q223 Q323 Q423 Q124 Q224 Revenues: Clearing and transaction fees 1,024.6 998.6 981.4 1,200.2 1,118.3 1,085.5 1,184.5 1,208.9 1,249.9 Market data and information services 151.7 154.3 153.2 165.8 163.1 167.6 167.2 175.4 175.0 Other Revenue 60.9 74.9 73.2 75.6 78.8 84.7 87.6 103.6 107.6 Total revenues 1,237.2 1,227.8 1,207.8 1,441.6 1,360.2 1,337.8 1,439.3 1,487.9 1,532.5 Expenses: Compensation and benefits 185.3 189.6 193.0 204.5 205.7 205.5 212.9 206.0 204.7 Technology 45.9 46.8 50.0 51.3 53.3 55.6 58.5 59.4 64.1 Professional fees and outside services 32.0 35.1 38.5 38.3 37.8 32.2 36.1 33.1 34.7 Amortization of purchased intangibles 57.1 55.5 56.7 56.8 57.0 57.2 55.6 55.2 55.5 Depreciation and amortization 33.0 34.5 33.9 31.9 32.3 31.1 30.7 30.1 28.7 Licensing and other fee agreements 83.1 83.6 72.4 84.7 78.2 79.5 80.4 87.9 85.9 Other expense 51.1 43.9 95.0 60.4 57.3 56.5 101.9 56.6 58.3 Operating expenses 487.5 489.0 539.5 527.9 521.6 517.6 576.1 528.3 531.9 Operating Income 749.7 738.8 668.3 913.7 838.6 820.2 863.2 959.6 1,000.6 Operating Margin 61% 60% 55% 63% 62% 61% 60% 64% 65% Non-operating Income and Expense Investment income 286.9 686.2 1,152.2 1,357.7 1,568.2 1,272.5 1,076.9 1,071.3 1,044.5 Interest and other borrowing costs (39.9) (40.4) (39.9) (39.9) (40.2) (39.6) (39.7) (39.9) (40.1) Equity in net gains (losses) of unconsolidated subsidiaries 87.3 76.5 64.0 78.2 75.1 76.8 66.8 87.2 86.4 Other non-operating income (expense) (217.3) (581.1) (1,017.3) (1,152.8) (1,425.3) (1,155.6) (961.2) (964.8) (936.9) Non-operating income (expense) 117.0 141.2 159.0 243.2 177.8 154.1 142.8 153.8 153.9 Income before income taxes 866.7 880.0 827.3 1,156.9 1,016.4 974.3 1,006.0 1,113.4 1,154.5 Income taxes 204.2 200.4 189.4 273.1 238.8 224.1 191.4 258.2 271.3 Net income 662.5 679.6 637.9 883.8 777.6 750.2 814.6 855.2 883.2 Less: net income (loss) attributable to NCI - - - - - - - - - Net Income Attributable to CME Group 662.5 679.6 637.9 883.8 777.6 750.2 814.6 855.2 883.2 Net Income Attributable to Common Shareholders of CME Group 654.1 671.1 629.9 872.7 767.8 740.8 804.3 844.4 872.1 Effective Tax Rate 23.6% 22.8% 22.8% 23.6% 23.5% 23.0% 19.0% 23.2% 23.2% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 1.82 1.87 1.76 2.43 2.14 2.06 2.24 2.35 2.43 Diluted EPS 1.82 1.87 1.75 2.43 2.14 2.06 2.24 2.35 2.42 Weighted average number of common stock shares: Basic Shares 358,641 358,715 358,885 358,933 358,940 359,020 359,197 359,258 359,330 Diluted Shares 359,205 359,288 359,190 359,313 359,429 359,619 359,693 359,833 359,869 Preferred Shares 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 -- 1 of 2 -- CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF NON-GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q222 Q322 Q422 Q123 Q223 Q323 Q423 Q124 Q224 Revenues: Clearing and transaction fees 1,024.6 998.6 981.4 1,200.2 1,118.3 1,085.5 1,184.5 1,208.9 1,249.9 Market data and information services 151.7 154.3 153.2 165.8 163.1 167.6 167.2 175.4 175.0 Other Revenue 60.9 74.9 73.2 75.6 78.8 84.7 87.6 103.6 106.6 Total revenues 1,237.2 1,227.8 1,207.8 1,441.6 1,360.2 1,337.8 1,439.3 1,487.9 1,531.5 Expenses: Compensation and benefits 189.5 189.1 184.6 192.8 194.4 193.5 204.4 196.1 201.7 Technology 45.9 46.8 50.0 51.3 53.3 55.6 58.5 59.4 64.1 Professional fees and outside services 31.4 35.1 38.5 38.3 37.8 32.2 36.1 33.1 34.7 Amortization of purchased intangibles - - - - - - - - - Depreciation and amortization 32.9 33.8 33.9 31.9 31.8 31.1 29.8 29.3 28.7 Licensing and other fee agreements 83.1 81.9 72.4 84.7 78.2 79.5 80.4 87.9 85.9 Other expense 59.6 54.4 84.5 59.7 56.2 56.5 80.3 56.5 58.6 Operating expenses 442.4 441.1 463.9 458.7 451.7 448.4 489.5 462.3 473.7 Operating Income 794.8 786.7 743.9 982.9 908.5 889.4 949.8 1,025.6 1,057.8 Operating Margin 64% 64% 62% 68% 67% 66% 66% 69% 69% Non-operating Income and Expense Investment income 299.5 688.5 1,147.1 1,277.5 1,564.0 1,276.6 1,068.5 1,061.7 1,033.0 Interest and other borrowing costs (39.9) (40.4) (39.9) (39.9) (40.2) (39.6) (39.7) (39.9) (40.1) Equity in net gains (losses) of unconsolidated subsidiaries 98.2 89.6 76.2 91.5 88.6 90.4 85.1 100.7 98.8 Other non-operating income (expense) (218.5) (585.7) (1,023.3) (1,160.6) (1,429.9) (1,157.1) (958.8) (964.8) (936.9) Non-operating income (expense) 139.3 152.0 160.1 168.5 182.5 170.3 155.1 157.7 154.8 Income before income taxes 934.1 938.7 904.0 1,151.4 1,091.0 1,059.7 1,104.9 1,183.3 1,212.6 Income taxes 217.6 219.6 206.0 269.1 254.6 241.7 240.2 272.2 280.4 Net income 716.5 719.1 698.0 882.3 836.4 818.0 864.7 911.1 932.2 Less: net income (loss) attributable to NCI - - - - - - - - - Net Income Attributable to CME Group 716.5 719.1 698.0 882.3 836.4 818.0 864.7 911.1 932.2 Net Income Attributable to Common Shareholders of CME Group 707.5 710.0 689.1 871.1 825.9 807.9 853.8 899.7 920.4 Effective Tax Rate 23.3% 23.4% 22.8% 23.4% 23.3% 22.8% 21.7% 23.0% 23.1% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 1.97 1.98 1.92 2.43 2.30 2.25 2.38 2.50 2.56 Diluted EPS 1.97 1.98 1.92 2.42 2.30 2.25 2.37 2.50 2.56 Weighted average number of common stock shares: Basic Shares 358,641 358,715 358,885 358,933 358,940 359,020 359,197 359,258 359,330 Diluted Shares 359,205 359,288 359,190 359,313 359,429 359,619 359,693 359,833 359,869 Preferred Shares 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 -- 2 of 2 --